Robert A. Weinberg declared at the AACR 2002 meeting "the fact that one has been unable to transform normal human cells into tumor cells has left us cancer biologists in an unbearable situation over the last decades". In his opinion, the embarrassing situation ended with the publication of their paper in Nature in 1999. Therein, Hahn et al. reported that three defined genetic events are sufficient to convert normal human cells into malignant tumor cells (Hahn et al. 1999) . However, after a while it turned out that the authors mistakenly introduced at least four "defined genetic elements"; instead of a large T vector and in addition to hTERT and H-ras, a vector containing the entire SV40 early region including small and large T was used (Hahn et al. 2002) .
It has been shown that large T antigen induces chromosomal instability and is capable of transforming human cells after prolonged culturing in vitro (Ray and Kraemer 1993) . Hence, P. Duesberg proposed that aneuploidy, induced by large T antigen and long-term culturing (50 population doublings were needed), finally lead to the transformation of those cells by changing the expression rate of thousands of genes (Li et al. 2000) .
As a response, W. C. Hahn tried to clone diploid cells out of those tumorigenic HA1ER cells he generated earlier (most of the cells were highly aneuploid) and presented his data in the Dec 15 2001 issue of Cancer Research (Zimonjic et al. 2001) .
In this article, the Weinberg group reports that the majority of the cells in two clones (HA1ER-2 and HA1ER-3) are diploid before and after formation of tumors in nude mice. The authors present flow cytometry results, although DNA content measurements are inadequate for karyotype analysis, because structural chromosomal aberrations and aneuploidy in the near diploid range cannot be detected. Consequently, the authors hoped that 4 SKY (Spectral Karyotyping) images of perfectly diploid karyotypes of those clones, before and after formation of tumors in nude mice, would finally convince the last critical reader that tumorigenicity does not require genomic instability. Frequencies of nonrandom chromosomal aberrations observed in this clone. The abbreviations used are: der, derivative chromosome; t, translocation; del, deletion; q, long arm To explain our discrepancies, W. C. Hahn suggested that "somewhere in the handling of the cells from Boston to Berkeley" (during this time I worked in the Duesberg Lab at UCBerkeley) "that there was selection of rare variants". Since the cells, I received, grew very well from the start, and since mFISH analysis was undertaken just 1 week after receipt, it is very unlikely that all "diploid cells" were overgrown by aneuploid ones (Table 1) . Moreover, as I cultured the cells under standard conditions (37C, 5%CO2, DMEM Gibco, 10% FBS Gibco, 1% Antibiotic/Antimycotic Gibco), it is highly unlikely that those chromosomal aberrations were induced in our lab.
In a recent Science article by J. Marx (Marx 2002) , Weinberg is cited again suggesting that the culture conditions in the Duesberg lab might have been too harsh. Ironically, nontumorigenic human fibroblasts (BJELB cells, I also received from R. A. Weinberg), although containing SV40 early region and hTERT, remained mainly diploid under the same conditions (74% of the cells contained no chromosomal aberrations). Contrary to Zimonjic's report, unbalanced chromosomal rearrangements were detected in 100% of HA1ER-2 and HA1ER-3 cells and this was before tumor formation in nude mice. Since unbalanced rearrangements are known to cause a change of gene expression in many genes (Phillips et al. 2001) , it was not proved that four defined genetic elements, that is small T, large T, hTERT and H-ras were sufficient to transform normal human embryonic kidney cells on their own.
Moreover, it was shown again that without chromosomal aberrations and at least transient chromosomal instability (CIN), malignant transformation of human epithelial cells does not occur. This still leaves cancer biologists in the unbearable situation mentioned above...
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